HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiraphorn Issara-Amphorn Selected Research

Fc gamma receptor IIB

1/2021Prominent Indomethacin-Induced Enteropathy in Fcgriib Defi-cient lupus Mice: An Impact of Macrophage Responses and Immune Deposition in Gut.
1/2020Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
1/2018The Synergy of Endotoxin and (1→3)-β-D-Glucan, from Gut Translocation, Worsens Sepsis Severity in a Lupus Model of Fc Gamma Receptor IIb-Deficient Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiraphorn Issara-Amphorn Research Topics

Disease

9Sepsis (Septicemia)
06/2022 - 05/2016
5Endotoxemia
06/2022 - 11/2016
4Inflammation (Inflammations)
06/2022 - 09/2020
3Dysbiosis
06/2022 - 05/2021
3Proteinuria
01/2021 - 01/2020
2Colitis
06/2022 - 01/2022
2Bacteremia
06/2022 - 01/2022
2Mucositis
06/2022 - 01/2022
2Hepatocellular Carcinoma (Hepatoma)
03/2021 - 09/2018
2Candidemia
01/2018 - 01/2017
2Acute Kidney Injury (Acute Renal Failure)
01/2017 - 05/2016
1Infections
01/2022
1Virus Diseases (Viral Diseases)
03/2021
1Lupus Nephritis
01/2021
1Coinfection
01/2021
1Septic Shock (Toxic Shock Syndrome)
11/2016
1Ulcer
12/2012
1Liver Neoplasms (Liver Cancer)
12/2012
1Liver Diseases (Liver Disease)
12/2012

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
06/2022 - 01/2017
5fluorescein isothiocyanate dextranIBA
06/2022 - 11/2016
4Dextran SulfateIBA
06/2022 - 11/2016
4SolutionsIBA
06/2022 - 11/2016
4EndotoxinsIBA
06/2022 - 11/2016
3LipopolysaccharidesIBA
01/2022 - 11/2019
3Fc gamma receptor IIBIBA
01/2021 - 01/2018
3Lipocalin-2IBA
11/2019 - 05/2016
3Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2016
2CreatinineIBA
01/2020 - 05/2016
2Interleukin-6 (Interleukin 6)IBA
11/2016 - 05/2016
1Caspase 3 (Caspase-3)IBA
06/2022
1beta-GlucansIBA
06/2022
1salicylhydroxamic acid (SHAM)IBA
01/2022
1AlbuminsIBA
03/2021
1LigandsIBA
03/2021
1Indomethacin (Indometacin)FDA LinkGeneric
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1pristane (pristan)IBA
09/2020
1Therapeutic UsesIBA
09/2020
1Syk KinaseIBA
01/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2020
1delta proteinIBA
09/2018
1Saline SolutionIBA
01/2017
1trichlorosucrose (sucralose)IBA
11/2016
1InterleukinsIBA
05/2016
1lipoarabinomannan (LAM)IBA
12/2012
1Complex MixturesIBA
12/2012
1CurcuminIBA
12/2012
1Antiviral Agents (Antivirals)IBA
12/2012

Therapy/Procedure

8Punctures
01/2020 - 05/2016
8Ligation
01/2020 - 05/2016
2Nephrectomy
05/2021 - 05/2016
2Oral Administration
01/2017 - 11/2016
1Splenectomy
01/2022